Alpha 2.0
Login Register
» Articles » PMID: 6980625

Beta-Lactamases of Branhamella Catarrhalis and Their Inhibition by Clavulanic Acid

Overview
Journal Antimicrob Agents Chemother
Publisher American Society for Microbiology
Specialty Pharmacology
Date 1982 Mar 1
PMID 6980625
Citations 27
Authors
T Farmer
C Reading
Affiliations
Soon will be listed here.
Abstract

Three of four clinical isolates of Branhamella catarrhalis from Belgium produced a beta-lactamase identical to enzymes previously reported to occur in French and British isolates of this organism. One strain, however, produced a new type of beta-lactamase. Both beta-lactamase types were readily inhibited by low concentrations of clavulanic acid.

Citing Articles

Antimicrobial resistance in Haemophilus influenzae and Moraxella catarrhalis respiratory tract isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002.

Zhanel G, Palatnick L, Nichol K, Low D, Hoban D Antimicrob Agents Chemother. 2003; 47(6):1875-81.

PMID: 12760861 PMC: 155833. DOI: 10.1128/AAC.47.6.1875-1881.2003.

Molecular characterization of the beta-lactamases from clinical isolates of Moraxella (Branhamella) catarrhalis obtained from 24 U.S. medical centers during 1994-1995 and 1997-1998.

Richter S, Winokur P, Brueggemann A, Huynh H, Rhomberg P, Wingert E Antimicrob Agents Chemother. 2000; 44(2):444-6.

PMID: 10639381 PMC: 89702. DOI: 10.1128/AAC.44.2.444-446.2000.

Interaction of Streptococcus pneumoniae and Moraxella catarrhalis: investigation of the indirect pathogenic role of beta-lactamase-producing moraxellae by use of a continuous-culture biofilm system.

Budhani R, Struthers J Antimicrob Agents Chemother. 1998; 42(10):2521-6.

PMID: 9756750 PMC: 105877. DOI: 10.1128/AAC.42.10.2521.

Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.

McGregor K, Chang B, Mee B, Riley T Eur J Clin Microbiol Infect Dis. 1998; 17(4):219-34.

PMID: 9707304 DOI: 10.1007/BF01699978.

[Moraxella catarrhalis: virulence and resistance mechanisms].

Cullmann W Med Klin (Munich). 1997; 92(3):162-6.

PMID: 9173208 DOI: 10.1007/BF03043274.

References
1.
Cole M, Elson S, Fullbrook P . Inhibition of the -lactamases of Escherichia coli and Klebsiella aerogenes by semi-synthetic penicillins. Biochem J. 1972; 127(1):295-308. PMC: 1178584. DOI: 10.1042/bj1270295. View
2.
OCALLAGHAN C, Morris A, Kirby S, Shingler A . Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate. Antimicrob Agents Chemother. 1972; 1(4):283-8. PMC: 444209. DOI: 10.1128/AAC.1.4.283. View
3.
McNeely D, Kitchens C, Kluge R . Fatal Neisseria (Branhamella) catarrhalis pneumonia in an immunodeficient host. Am Rev Respir Dis. 1976; 114(2):399-402. DOI: 10.1164/arrd.1976.114.2.399. View
4.
NINANE G, Joly J, Piot P, Kraytman M . Branhamella (Neisseria) catarrhalis as pathogen. Lancet. 1977; 2(8029):149. DOI: 10.1016/s0140-6736(77)90171-4. View
5.
Reading C, Cole M . Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus. Antimicrob Agents Chemother. 1977; 11(5):852-7. PMC: 352086. DOI: 10.1128/AAC.11.5.852. View